1
Clinical Trials associated with LCAR-M61SQ Cell(First Affiliated Hospital of Wenzhou Medical University) / Not yet recruitingNot ApplicableIIT A Clinical Study to Evaluate the Safety, Tolerance and Efficacy of LCAR-M61SQ Cell in Patients with Relapsed/Refractory Multiple Myeloma.
A prospective, open-label dose-exploration and expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor efficacy characteristics of LCAR-M61SQ in patients with relapsed/refractory multiple myeloma.
100 Clinical Results associated with LCAR-M61SQ Cell(First Affiliated Hospital of Wenzhou Medical University)
100 Translational Medicine associated with LCAR-M61SQ Cell(First Affiliated Hospital of Wenzhou Medical University)
100 Patents (Medical) associated with LCAR-M61SQ Cell(First Affiliated Hospital of Wenzhou Medical University)
100 Deals associated with LCAR-M61SQ Cell(First Affiliated Hospital of Wenzhou Medical University)